Publications & Reports

PfRH5 as a candidate vaccine for Plasmodium falciparum malaria.

Drew DR, Beeson JG
Burnet Institute, 85 Commercial Road, Melbourne, Victoria, Australia.


PfRH5 has recently emerged as a strong vaccine candidate for Plasmodium falciparum malaria. Antibodies inhibit invasion of erythrocytes by merozoites and blood-stage replication, and PfRH5 is a significant target of acquired human immunity. Recent studies have shown protective efficacy of PfRH5 vaccines in a non-human primate model of malaria.


  • Journal: Trends in Parasitology
  • Published: 19/02/2015
  • Volume: 31
  • Issue: 3
  • Pagination: 87-88


Health Issue